Absol Developers

Baseline chronic kidney disease (CKD) is an important risk factor for cardiovascular illness, hospitalization and mortality — and these risks are greater at higher stages of CKD. Furthermore, progression from a lesser stage to CKD stage 3B or higher (eGFR < 45 mL/min/1.73m2) has been associated with increased cardiovascular events and mortality, irrespective of other […]

Regular urine color ranges from clear to pale yellow. But certain things can change the color. Foods such as beets, blackberries, and fava beans can turn urine pink or red, for example. And some medicines can give urine vivid tones, such as orange or greenish-blue. An unusual urine color also can be a sign of

Radical cystectomy and urinary diversion remains the cornerstone in surgical management of patients with muscle-invasive or high-risk nonmuscle-invasive bladder cancer. This approach has been associated with remarkable increase in patient survival and more patients are now living for years after surgery who may present with long-term complications. This review describes long-term complications associated with urinary diversion including renal function

What is enuresis in children? Urinary incontinence (enuresis) is the loss of bladder control. In children younger than age 3, it’s normal to not have full bladder control. As children get older, they become more able to control their bladder. Wetting is called enuresis when it happens in a child who is old enough to

Pancreatic cancer is one of the deadliest types of cancer-;in the U.S., it is estimated that over 88 percent of people will die from the disease within five years of their diagnosis. One reason for this bleak prognosis is that the majority of pancreatic cancers are diagnosed after the disease has already spread, or metastasized,

Prostate cancer is the second-leading cause of cancer death in men with more than 34,000 deaths in the U.S. each year, according to the American Cancer Society. But guidelines for prostate cancer screening are continually shifting, leading to uncertainty among patients and providers on when and if screening tests should be ordered. In a new

Researchers have developed an optimized genetic test for ovarian cancer, which helps accurately target an effective but expensive medication. The drug has significantly improved the prognosis of ovarian cancer patients. A genetic test developed in a study at the University of Helsinki and Helsinki University Hospital identifies ovarian cancer patients who benefit from PARP inhibitors,